Chitosan Oligosaccharide-Functionalized Ruthenium-Curcumin Nanodots for Targeted Therapy of Acute Kidney Injury
International Journal of Nanomedicine · 2026-06 · Volume 21 · 1-19
DOI: 10.2147/ijn.s601940 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-06. Verfasst von Qin Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beilun People's Hospital, Ningbo, Zhejiang, 315800, People's Republic of China. Hauptthemen laut MEDLINE: Curcumin, Chitosan, Acute Kidney Injury, Ruthenium. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a critical clinical syndrome with high morbidity and mortality, primarily driven by mitochondrial oxidative stress and tubular epithelial cell apoptosis. Current antioxidant therapies are limited by poor bioavailability and lack of renal specificity. To address this, we developed a dual-targeting nanomedicine based on ultrasmall chitosan oligosaccharide-functionalized ruthenium-curcumin nanodots (LMWC/Ru-Cur).
Methods
Ru-Cur coordination polymer nanodots were synthesized and subsequently coated with low-molecular-weight chitosan (LMWC). The nanoparticles were characterized for size, surface charge, stability, and antioxidant capacity. In vitro studies using HK-2 cells assessed cytocompatibility, cellular uptake, and protection against H2O2- or cisplatin-induced injury via measurements of viability, mitochondrial ROS, membrane potential, and apoptosis. In vivo efficacy and biodistribution were evaluated in murine models of ischemia-reperfusion- and cisplatin-induced AKI.
Results
The resulting LMWC/Ru-Cur nanodots exhibited uniform size (~7.6 nm), good aqueous stability, and potent broad-spectrum radical scavenging ability. They were efficiently internalized by renal tubular cells via megalin receptor-mediated endocytosis, leading to significantly enhanced renal accumulation. Treatment with LMWC/Ru-Cur attenuated oxidative stress, restored mitochondrial function, reduced apoptosis in injured HK-2 cells, and improved renal function (serum creatinine and blood urea nitrogen), histopathology, and inflammatory cytokine levels in both AKI models, outperforming free curcumin or unmodified Ru-Cur. The nanodots also demonstrated favorable short-term biocompatibility and in vivo biosafety.
Conclusion
LMWC/Ru-Cur nanodots represent a promising targeted nanotherapeutic strategy for AKI, integrating passive glomerular filtration with active receptor-mediated tubular delivery to effectively mitigate oxidative stress and mitochondrial damage, thereby preserving renal function. This work provides a rational design for metal-polyphenol based nanomedicines in the treatment of acute organ injury. Keywords: acute kidney injury, reactive oxygen species, curcumin, megalin receptor, apoptosis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Beilun People's Hospital, Ningbo, Zhejiang, 315800, People's Republic of China.
- College of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, 315000, People's Republic of China.
- Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, People's Republic of China.
- Department of Nephrology, Beilun People's Hospital, Ningbo, Zhejiang, 315800, People's Republic of China.
Zitieren
APA
Yu, Q., Tan, X. Y., Liu, X., Mao, H. B., & Chen, Z. G. (2026). Chitosan Oligosaccharide-Functionalized Ruthenium-Curcumin Nanodots for Targeted Therapy of Acute Kidney Injury. International Journal of Nanomedicine, Volume 21, 1-19. https://doi.org/10.2147/ijn.s601940
Vancouver
Yu Q, Tan XY, Liu X, Mao HB, Chen ZG. Chitosan Oligosaccharide-Functionalized Ruthenium-Curcumin Nanodots for Targeted Therapy of Acute Kidney Injury. International Journal of Nanomedicine. 2026;Volume 21:1-19. doi:10.2147/ijn.s601940
BibTeX
@article{Yu2026,
author = {Yu, Qin and Tan, Xue-Ying and Liu, Xian and Mao, Hai-Bo and Chen, Zhao-Gui},
title = {Chitosan Oligosaccharide-Functionalized Ruthenium-Curcumin Nanodots for Targeted Therapy of Acute Kidney Injury},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--19},
doi = {10.2147/ijn.s601940}
}
EUVIMED